Clinical Trials Browser

Completed × NIH × NET × Clear all

NCT01967537 2019-11-19

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Phase 2 Completed

341 enrolled 14 charts

von Hippel-Lindau Disease, Neuroendocrine Tumors